| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.799 | 5.514 | 11.429 | 27.434 | 21.020 | 30.865 | 24.715 |
| Total Income - EUR | - | - | - | 3.799 | 5.520 | 11.429 | 27.434 | 21.085 | 30.865 | 26.815 |
| Total Expenses - EUR | - | - | - | 817 | 1.246 | 4.960 | 0 | 16.883 | 31.277 | 28.377 |
| Gross Profit/Loss - EUR | - | - | - | 2.982 | 4.274 | 6.469 | 27.434 | 4.202 | -412 | -1.562 |
| Net Profit/Loss - EUR | - | - | - | 2.868 | 4.109 | 6.147 | 26.751 | 3.786 | -603 | -1.632 |
| Employees | - | - | - | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Fda Medical Practice S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 29 | 28 | 28 | 27 | 1.172 | 2.282 | 16.603 |
| Current Assets | - | - | - | 3.133 | 7.429 | 13.757 | 40.886 | 37.298 | 36.078 | 25.957 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 4.270 | 0 |
| Receivables | - | - | - | 0 | 3.232 | 9.993 | 30.331 | 20.650 | 20.874 | 18.447 |
| Cash | - | - | - | 3.133 | 4.197 | 3.764 | 10.556 | 16.648 | 10.934 | 7.510 |
| Shareholders Funds | - | - | - | 2.911 | 6.963 | 12.978 | 39.441 | 38.239 | 37.520 | 28.687 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 251 | 494 | 807 | 1.473 | 231 | 840 | 13.874 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Fda Medical Practice S.r.l.